Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
65,96 USD | +2,14% | +1,82% | -18,58% |
CA 2024 * | 27,6 Md 25 Md | CA 2025 * | 28 Md 25,36 Md | Capitalisation | 82,18 Md 74,44 Md |
---|---|---|---|---|---|
Résultat net 2024 * | 403 M 365 M | Résultat net 2025 * | 6,35 Md 5,76 Md | VE / CA 2024 * | 3,64 x |
Dette nette 2024 * | 18,15 Md 16,44 Md | Dette nette 2025 * | 12,68 Md 11,49 Md | VE / CA 2025 * | 3,39 x |
PER 2024 * |
187
x | PER 2025 * |
12,6
x | Employés | 18 000 |
Rendement 2024 * |
4,69% | Rendement 2025 * |
4,93% | Flottant | 99,9% |
Dernier transcript sur Gilead Sciences, Inc.
1 jour | +2,14% | ||
1 semaine | +1,82% | ||
Mois en cours | +1,17% | ||
1 mois | -3,17% | ||
3 mois | -10,47% | ||
6 mois | -13,12% | ||
Année en cours | -18,58% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 59 | 01/03/19 |
Andrew Dickinson
DFI | Director of Finance/CFO | 54 | 01/01/16 |
Flavius Martin
CTO | Chief Tech/Sci/R&D Officer | - | 12/04/21 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Anthony Welters
BRD | Director/Board Member | 69 | 17/10/20 |
Director/Board Member | 71 | 01/01/18 | |
Ted Love
BRD | Director/Board Member | 65 | 01/02 |
Mnemo | Type | Type de produit | Maturité | Elasticité | Levier | Parité | Cours | Emetteur |
---|---|---|---|---|---|---|---|---|
CALL
| CALL | Certificat Turbo Stop Loss | Illimité | - | 20 | 0.41 0.4 |
Vontobel
| |
CALL
| CALL | Certificat Turbo | Illimité | - | 20 | 0.55 0.54 |
Vontobel
| |
CALL
| CALL | Certificat Turbo Stop Loss | Illimité | - | 20 | 0.63 0.62 |
Vontobel
| |
CALL
| CALL | Certificat Turbo | Illimité | - | 20 | 0.33 0.32 |
Vontobel
| |
CALL
| CALL | Certificat Turbo | Illimité | - | 20 | 0.77 0.76 |
Vontobel
| |
Nom | Poids | Encours | Varia. 1 janv. | Note Invest. |
---|---|---|---|---|
13,99% | 0 M€ | +12,39% | - | |
8,10% | 0 M€ | 0,00% | - | |
8,06% | 0 M€ | 0,00% | - | |
5,23% | 2 M€ | -.--% |
Nom | PEA | Position | Varia. 1 janv. | Notation |
---|---|---|---|---|
INVESCO SOCIAL PROGRESS A-ACC SHARES EUR | Non | 0.2M EUR | +9,00% | |
FRANKLIN BIOTECHNOLOGY DISCV A(ACC)USD | Non | 69.53M USD | +5,00% | |
INVESCO SUST US STRUCT EQ A USD ACC | Non | 0.47M USD | +9,00% | |
BSO BIO SANTÉ C | Non | 5.18M EUR | -7,00% | |
AXAWF II NORTH AMERICAN EQS A DIS USD | Non | 2.29M USD | +15,00% |
Date | Cours | Variation | Volume |
---|---|---|---|
10/05/24 | 65,96 | +2,14% | 8 733 211 |
09/05/24 | 64,58 | -0,52% | 6 048 572 |
08/05/24 | 64,92 | -0,82% | 5 134 980 |
07/05/24 | 65,46 | -0,12% | 7 318 161 |
06/05/24 | 65,54 | +1,17% | 7 187 265 |
Cours en différé Nasdaq, Le 10 mai 2024 à 22:00
Plus de cotationsRévisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-18,58% | 82,18 Md | |
+30,38% | 684 Md | |
+26,51% | 568 Md | |
-4,36% | 361 Md | |
+19,30% | 329 Md | |
+3,73% | 284 Md | |
+16,70% | 240 Md | |
+8,78% | 208 Md | |
-7,93% | 200 Md | |
+7,68% | 166 Md |